185 related articles for article (PubMed ID: 7780954)
1. A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma.
Herbst RA; Larson A; Weiss J; Cavenee WK; Hampton GM; Arden KC
Cancer Res; 1995 Jun; 55(12):2494-6. PubMed ID: 7780954
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity for 10q22-10qter in malignant melanoma progression.
Herbst RA; Weiss J; Ehnis A; Cavenee WK; Arden KC
Cancer Res; 1994 Jun; 54(12):3111-4. PubMed ID: 8205526
[TBL] [Abstract][Full Text] [Related]
3. Identification of two distinct deletion targets at 11q23 in cutaneous malignant melanoma.
Herbst RA; Gutzmer R; Matiaske F; Mommert S; Casper U; Kapp A; Weiss J
Int J Cancer; 1999 Jan; 80(2):205-9. PubMed ID: 9935201
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
[TBL] [Abstract][Full Text] [Related]
5. Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer.
Davis M; Hitchcock A; Foulkes WD; Campbell IG
Cancer Res; 1996 Feb; 56(4):741-4. PubMed ID: 8631007
[TBL] [Abstract][Full Text] [Related]
6. Functional localization of a melanoma tumor suppressor gene to a small (< or = 2 Mb) region on 11q23.
Robertson GP; Goldberg EK; Lugo TG; Fountain JW
Oncogene; 1999 May; 18(20):3173-80. PubMed ID: 10340390
[TBL] [Abstract][Full Text] [Related]
7. A malignant melanoma tumor suppressor on human chromosome 11.
Robertson G; Coleman A; Lugo TG
Cancer Res; 1996 Oct; 56(19):4487-92. PubMed ID: 8813145
[TBL] [Abstract][Full Text] [Related]
8. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
Pollock PM; Welch J; Hayward NK
Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
[TBL] [Abstract][Full Text] [Related]
9. Large deletions of chromosome 9p in cutaneous malignant melanoma identify patients with a high risk of developing metastases. Hospital Clinic Malignant Melanoma Group, University of Barcelona.
Puig S; Castro J; Ventura PJ; Ruiz A; Ascaso C; Malvehy J; Estivill X; Mascaro JM; Lecha M; Castel T
Melanoma Res; 2000 Jun; 10(3):231-6. PubMed ID: 10890376
[TBL] [Abstract][Full Text] [Related]
10. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.
Healy E; Belgaid CE; Takata M; Vahlquist A; Rehman I; Rigby H; Rees JL
Cancer Res; 1996 Feb; 56(3):589-93. PubMed ID: 8564976
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour.
Grundy RG; Pritchard J; Scambler P; Cowell JK
Oncogene; 1998 Jul; 17(3):395-400. PubMed ID: 9690521
[TBL] [Abstract][Full Text] [Related]
12. CDKN2A mutation and deletion status in thin and thick primary melanoma.
Cachia AR; Indsto JO; McLaren KM; Mann GJ; Arends MJ
Clin Cancer Res; 2000 Sep; 6(9):3511-5. PubMed ID: 10999737
[TBL] [Abstract][Full Text] [Related]
13. Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma.
Parris CN; Harris JD; Griffin DK; Cuthbert AP; Silver AJ; Newbold RF
Cancer Res; 1999 Feb; 59(3):516-20. PubMed ID: 9973191
[TBL] [Abstract][Full Text] [Related]
14. 9p21 deletions in primary melanoma.
Naylor MF; Brown S; Quinlan C; Pitha JV; Evertt MA
Dermatol Online J; 1997 Dec; 3(2):1. PubMed ID: 9452367
[TBL] [Abstract][Full Text] [Related]
15. Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival.
Grafström E; Egyházi S; Ringborg U; Hansson J; Platz A
Clin Cancer Res; 2005 Apr; 11(8):2991-7. PubMed ID: 15837753
[TBL] [Abstract][Full Text] [Related]
16. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
17. Frequent loss of heterozygosity targeting the inactive X chromosome in melanoma.
Indsto JO; Nassif NT; Kefford RF; Mann GJ
Clin Cancer Res; 2003 Dec; 9(17):6476-82. PubMed ID: 14695151
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma.
Holland EA; Beaton SC; Edwards BG; Kefford RF; Mann GJ
Oncogene; 1994 May; 9(5):1361-5. PubMed ID: 8152796
[TBL] [Abstract][Full Text] [Related]
19. Chromosome 9 deletion in sporadic and familial melanomas in vivo.
Isshiki K; Seng BA; Elder DE; Guerry D; Linnenbach AJ
Oncogene; 1994 Jun; 9(6):1649-53. PubMed ID: 8183559
[TBL] [Abstract][Full Text] [Related]
20. Interstitial deletions at the long arm of chromosome 13 may be as common as monosomies in multiple myeloma. A genotypic study.
Nomdedéu JF; Lasa A; Ubeda J; Saglio G; Bellido M; Casas S; Carnicer MJ; Aventín A; Sureda A; Sierra J; Baiget M
Haematologica; 2002 Aug; 87(8):828-35. PubMed ID: 12161359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
